Document Detail


Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokers.
MedLine Citation:
PMID:  23312475     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The fifth edition of the diagnostic and statistical manual of mental disorders (DSM-5) proposes aligning nicotine use disorder (NUD) criteria with those for other substances, by including the current DSM fourth edition (DSM-IV) nicotine dependence (ND) criteria, three abuse criteria (neglect roles, hazardous use, interpersonal problems) and craving. Although NUD criteria indicate one latent trait, evidence is lacking on: (1) validity of each criterion ; (2) validity of the criteria as a set ; (3) comparative validity between DSM-5 NUD and DSM-IV ND criterion sets ; and (4) NUD prevalence.
METHOD: Nicotine criteria (DSM-IV ND, abuse and craving) and external validators (e.g., smoking soon after awakening, number of cigarettes per day) were assessed with a structured interview in 734 lifetime smokers from an Israeli household sample. Regression analysis evaluated the association between validators and each criterion. Receiver operating characteristic analysis assessed the association of the validators with the DSM-5 NUD set (number of criteria endorsed) and tested whether DSM-5 or DSM-IV provided the most discriminating criterion set. Changes in prevalence were examined.
RESULTS: Each DSM-5 NUD criterion was significantly associated with the validators, with strength of associations similar across the criteria. As a set, DSM-5 criteria were significantly associated with the validators, were significantly more discriminating than DSM-IV ND criteria, and led to increased prevalence of binary NUD (two or more criteria) over ND.
CONCLUSIONS: All findings address previous concerns about the DSM-IV nicotine diagnosis and its criteria and support the proposed changes for DSM-5 NUD, which should result in improved diagnosis of nicotine disorders.
Authors:
D Shmulewitz; M M Wall; E Aharonovich; B Spivak; A Weizman; A Frisch; B F Grant; D Hasin
Related Documents :
12658625 - The spanish-language version of the diagnostic interview for dsm-iv personality disorde...
19840585 - Does personality disorder decrease the likelihood of remission in early-onset chronic d...
8085995 - The prevalence of respiratory disorders in panic disorder, major depressive disorder an...
15615665 - Two-year stability of personality disorder in older adolescent outpatients.
18212115 - Role of gsk3 beta in behavioral abnormalities induced by serotonin deficiency.
21981955 - Etiology and treatment of hypogonadism in adolescents.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2013-01-14
Journal Detail:
Title:  Psychological medicine     Volume:  43     ISSN:  1469-8978     ISO Abbreviation:  Psychol Med     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-08-30     Completed Date:  2014-04-22     Revised Date:  2014-10-12    
Medline Journal Info:
Nlm Unique ID:  1254142     Medline TA:  Psychol Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  2179-90     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Diagnostic and Statistical Manual of Mental Disorders*
Female
Humans
Israel / epidemiology
Male
Middle Aged
Prevalence
Psychiatric Status Rating Scales / standards*
Reproducibility of Results
Smoking / epidemiology,  physiopathology*
Tobacco Use Disorder / diagnosis*,  epidemiology
Young Adult
Grant Support
ID/Acronym/Agency:
K05 AA014223/AA/NIAAA NIH HHS; K05AA014223/AA/NIAAA NIH HHS; K23 DA016743/DA/NIDA NIH HHS; K23DA016743/DA/NIDA NIH HHS; R01 AA013654/AA/NIAAA NIH HHS; R01 DA018652/DA/NIDA NIH HHS; R01AA013654/AA/NIAAA NIH HHS; R01DA018652/DA/NIDA NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally activ...
Next Document:  DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism.